Please login to the form below

Not currently logged in
Email:
Password:

Fishawack expands its teams

Fishawack has appointed two new industry experts to its group: Linda Harris and Jo Jarvis

Fishawack has appointed two new industry experts to its group: Linda Harris and Jo Jarvis.

Industry veteran Linda Harris joined the US team in September 2010 as vice president, Stakeholder and Thought Leader Strategies.

The appointments follow Fishawack's recruitment of eight new starters in March.

Linda's 30 years of experience in pharma sales and marketing includes positions at Sandoz, Novartis, and Wyeth (now Pfizer), where she was assistant vice president of the Opinion Leader Relations department.

In addition, Jo Jarvis recently joined the Fishawack UK team as director, Stakeholder Strategies. Jo was at Wyeth for more than 20 years, most recently as head of Advocacy.

Building on their working relationship, the two will be serving as faculty at the upcoming Centre for Business Intelligence conference on May 24-25 in San Diego, titled 'Inaugural West Coast Forum on Defining Compliant and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs) to Support Product Development and Commercialisation.'

An online stakeholder relations portal will also be developed and executed later this year.

According to Fishawack CEO, Oliver Dennis: "There is an unfulfilled need for a standardised approach to managing these important relationships, and we're excited to be able to pioneer these services through the unique insight of our experienced industry professionals and in-house experts."

19th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics